FLI1 and Ewing sarcoma: In case #2 with relapsed EWSR1:FLI1-positive Ewing sarcoma, serial viable tissue sampling with DSP before and after therapy allowed us to monitor the evolution of drug resistance under multiagent chemo- and targeted therapy.